60 Degrees PharmaceuticalsSXTP -1.75%44 Net Debt Paydown Yield % is 0.08% as of Jul. 06, 2026, which is 100% below its 10-year median of 158.57. GuruFocus rates SXTP with a GF Scoreâ„¢ of 44/100 and a GF Valueâ„¢ of $2.04 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,159 Biotechnology companies, 60 Degrees Pharmaceuticals ranks better than 54.44% on this metric.
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
As of today, 60 Degrees Pharmaceuticals's Net Debt Paydown Yield % was 0.08%.
60 Degrees Pharmaceuticals (NAS:SXTP) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
60 Degrees Pharmaceuticals Net Debt Paydown Yield % Chart
SXTP vs GLMD, FBLG, CELZ: Net Debt Paydown Yield % Comparison
For the Biotechnology subindustry, 60 Degrees Pharmaceuticals's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
60 Degrees Pharmaceuticals Net Debt Paydown Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 60 Degrees Pharmaceuticals's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where 60 Degrees Pharmaceuticals's Net Debt Paydown Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
What does a Net Debt Paydown Yield % of 0.08% mean?
60 Degrees Pharmaceuticals (SXTP) has a Net Debt Paydown Yield % of 0.08% as of Jul. 06, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on 60 Degrees Pharmaceuticals and its competitors. This is 100% below median its historical median of 158.57. Over the past decade, 60 Degrees Pharmaceuticals' Net Debt Paydown Yield % has ranged from 0.08 to 774.45. According to the industry distribution chart, 60 Degrees Pharmaceuticals ranks #528 out of 1159 companies in the Biotechnology industry, placing it in the top 45.6%.
Is 60 Degrees Pharmaceuticals' Net Debt Paydown Yield % too high?
60 Degrees Pharmaceuticals' current Net Debt Paydown Yield % of 0.08% is 100% below median its 10-year median of 158.57. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 774.45. The Biotechnology industry median Net Debt Paydown Yield % is 0.03. 60 Degrees Pharmaceuticals' value of 0.08% is 166.7% above this industry median. Based on the distribution chart, 60 Degrees Pharmaceuticals ranks #528 out of 1159 companies in the Biotechnology industry, which is above the industry midpoint. Overall, 60 Degrees Pharmaceuticals has a GF Scoreâ„¢ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 60 Degrees Pharmaceuticals' Net Debt Paydown Yield % compare to GLMD and FBLG?
According to the Biotechnology industry distribution chart, 60 Degrees Pharmaceuticals ranks #528 out of 1159 companies for Net Debt Paydown Yield %. This puts 60 Degrees Pharmaceuticals in the upper half of its industry. The industry median Net Debt Paydown Yield % is 0.03. 60 Degrees Pharmaceuticals' value of 0.08% is 166.7% above this benchmark. Historically, 60 Degrees Pharmaceuticals' own Net Debt Paydown Yield % has ranged from 0.08 to 774.45 over the past decade. While the company's 10-year median is 158.57 vs. the industry median of 0.03, 60 Degrees Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Biotechnology company?
The median Net Debt Paydown Yield % among Biotechnology companies is 0.03, based on 1,159 companies in the industry. Companies in the top quartile (top 25%) have a Net Debt Paydown Yield % significantly above this median, while those in the bottom quartile fall well below. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 60 Degrees Pharmaceuticals's current Net Debt Paydown Yield % of 0.08% is 166.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on 60 Degrees Pharmaceuticals and its competitors. For the Biotechnology industry, the median Net Debt Paydown Yield % is 0.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 60 Degrees Pharmaceuticals's current Net Debt Paydown Yield % is 0.08%, which is 100% below median its own 10-year median of 158.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 60 Degrees Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals (SXTP) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.04, compared to a current price of $1.68 — trading 17.6% below its estimated fair value. The current Net Debt Paydown Yield % is 0.08%, which is 100% below median its 10-year median of 158.57 and 166.7% above the Biotechnology industry median of 0.03. 60 Degrees Pharmaceuticals' overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For 60 Degrees Pharmaceuticals (SXTP), the current Net Debt Paydown Yield % is 0.08% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 60 Degrees Pharmaceuticals (SXTP) Overvalued in 2026?
Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals stock appears to be undervalued.
The current stock price of $1.68 is trading 17.6% below its estimated GF Value™ of $2.04.
GuruFocus considers 60 Degrees Pharmaceuticals to be Modestly Undervalued.
Key valuation signals for SXTP:
Net Debt Paydown Yield %: 0.08% (100% below median its 10-year median of 158.57)
GF Value™: $2.04 vs. price of $1.68 (17.6% below fair value)
Industry Position: 166.7% above the Biotechnology median (#528 of 1159)
No single metric tells the full story. See the SXTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
44GF Score
Get the complete analysis for SXTP
Net Debt Paydown Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SXTP has been successfully added to your 
